BioRegenx, Inc. (BRGX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.0001 (-50.00%)
At close: Nov 4, 2026
BioRegenx Revenue
BioRegenx had revenue of $426.18K in the quarter ending March 31, 2026, a decrease of -17.27%. This brings the company's total for the last twelve months to $1.77M, down -23.43% year-over-year. In the year 2025, BioRegenx had annual revenue of $1.85M, down -20.75%. That makes BioRegenx the 42,647th largest company in the world by revenue and 5,836th in the United States.
Revenue (ttm)
1.77M
Revenue Growth
-23.43%
P/S Ratio
0.06
Revenue / Employee
n/a
Employees
6
Market Cap
97.16K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.85M | -485.59K | -20.75% |
| Dec 31, 2024 | 2.34M | -1.07M | -31.40% |
| Dec 31, 2023 | 3.41M | 974.09K | 39.97% |
| Dec 31, 2022 | 2.44M | -1.55M | -38.88% |
| Dec 31, 2021 | 3.99M | -3.80M | -48.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| LiveCare | 3.60M |
| Net Medical Xpress Solutions | 2.68M |
| SOAFEE | 2.23M |
| Optimus Healthcare Services | 1.82M |
| AMJ Global Technology | 705.00 |
BioRegenx News
- 1 year ago - BioRegenx, Inc. Engages Sichenzia Ross Ference Carmel LLP for Legal Representation in Connection with Planned Uplisting to National Stock Exchange - Accesswire